Oxler Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $745K | Hold |
1,674
| – | – | 0.23% | 51 |
|
|
2025
Q1 | $812K | Sell |
1,674
-110
| -6% | -$53.3K | 0.29% | 47 |
|
|
2024
Q4 | $718K | Hold |
1,784
| – | – | 0.24% | 52 |
|
|
2024
Q3 | $830K | Hold |
1,784
| – | – | 0.29% | 47 |
|
|
2024
Q2 | $836K | Hold |
1,784
| – | – | 0.31% | 46 |
|
|
2024
Q1 | $746K | Buy |
+1,784
| New | +$746K | 0.29% | 52 |
|
|
2023
Q4 | – | Sell |
-1,796
| Closed | -$625K | – | 93 |
|
|
2023
Q3 | $625K | Hold |
1,796
| – | – | 0.31% | 61 |
|
|
2023
Q2 | $632K | Sell |
1,796
-101
| -5% | -$35.5K | 0.3% | 65 |
|
|
2023
Q1 | $598K | Hold |
1,897
| – | – | 0.3% | 66 |
|
|
2022
Q4 | $548K | Hold |
1,897
| – | – | 0.29% | 66 |
|
|
2022
Q3 | $549K | Hold |
1,897
| – | – | 0.31% | 69 |
|
|
2022
Q2 | $535K | Buy |
+1,897
| New | +$535K | 0.26% | 76 |
|